Aug 09, 2023 / 04:00PM GMT
Kyle Mikson - Cannacord Genuity - Analyst
Welcome to the Canaccord Genuity global growth conference. I'm Kyle Mikson, over at life science, tools, and diagnostics for Canaccord. Pleased to have Castle Biosciences here with us today. Castle is a company that provides many diagnostic tests across dermatology, cancer, mental health, and GI cancer as well. So we have Derek Maetzold, the CEO of the company, and he's going to run through some slides to start us off. So go ahead, Derek, thanks for joining.
Derek Maetzold - Castle Biosciences, Inc. - President, CEO & Director
Thank you, Kyle and Canaccord, for the opportunity to be here in Boston yet again. Let's get started here. So let's see, disclaimer slide. So Castle Biosciences is a molecular diagnostics company predominantly focused on providing high-value diagnostic tests that help inform better patient management for a variety of conditions. Our largest franchise is in dermatology, where we have three proprietary gene expression profile tests: DecisionDX-Melanoma, DecisionDx-SCC, and MyPath Melanoma.
Castle Biosciences Inc at Canaccord Genuity Growth Conference Transcript
Aug 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers